The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes

Andreas Höhn*, Anita Jeyam, Thomas M. Caparrotta, Stuart J. McGurnaghan, Joseph E. O’Reilly, Luke A. K. Blackbourn, Rory J. McCrimmon, Graham P. Leese, John A. McKnight, Brian Kennon, Robert S. Lindsay, Naveed Sattar, Sarah H. Wild, Paul M. McKeigue, Helen M. Colhoun

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science